RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 50 filers reported holding RAIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,584 | -77.3% | 18,084 | -68.4% | 0.00% | – |
| Q2 2023 | $68,682 | -67.7% | 57,235 | +135.3% | 0.00% | – |
| Q1 2023 | $212,556 | +116.2% | 24,320 | +97.9% | 0.00% | – |
| Q4 2022 | $98,296 | +85.5% | 12,287 | +11.8% | 0.00% | – |
| Q3 2022 | $53,000 | -49.5% | 10,987 | -41.2% | 0.00% | – |
| Q2 2022 | $105,000 | +138.6% | 18,670 | +114.2% | 0.00% | – |
| Q1 2022 | $44,000 | -30.2% | 8,717 | +77.9% | 0.00% | – |
| Q4 2021 | $63,000 | +200.0% | 4,901 | +235.2% | 0.00% | – |
| Q3 2021 | $21,000 | +320.0% | 1,462 | +272.0% | 0.00% | – |
| Q2 2021 | $5,000 | – | 393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |